It was reported that a low dosage of decitabine induced DNA demethylation at the promoters of tumor suppressor genes, such as CDKN2B (p15INK4B) and E-cadherin, and thereby reactivated their expression in AML cells [121]. The gene discussed is CDKN2B; the disease is acute myeloid leukemia.